rxfast.net Quick Pharmacy Navigator

Tag: Paragraph IV certification

Why the First Generic Drug Filer Gets 180 Days of Market Exclusivity
Pharmacy

Why the First Generic Drug Filer Gets 180 Days of Market Exclusivity

  • Gareth Wycliffe
  • Dec 10, 2025

The first generic drug filer gets 180 days of exclusive market rights under the Hatch-Waxman Act. This rule was meant to lower drug prices-but loopholes let companies delay competition. Here’s how it works, who benefits, and why reform is overdue.

Recent Posts
  • Top 9 Alternatives to Drugwatch.com in 2025 Jan 3, 2025
  • Immunosuppression from Corticosteroids: How to Reduce Infection Risk Feb 19, 2026
  • Top 10 Alternatives to GoodRx.com in 2025 Mar 24, 2025
  • Barrier Repair in Eczema: How Ceramides and Proper Bathing Fix Dry, Itchy Skin Nov 16, 2025
  • ALS Care: How Noninvasive Ventilation and Nutrition Strategies Extend Life and Improve Daily Living Dec 20, 2025
Categories
  • Health (88)
  • Pharmacy (84)
  • Medications (68)
  • Supplements (3)
  • Investments (1)
Tag Clouds
  • online pharmacy
  • medication safety
  • drug interactions
  • generic drugs
  • online pharmacy safety
  • medication adherence
  • generic medications
  • Hatch-Waxman Act
  • therapeutic equivalence
  • GoodRx coupons
  • pharmacovigilance
  • medication side effects
  • 180-day exclusivity
  • DOACs
  • blood thinners
  • bioequivalence
  • telemedicine prescription
  • fertility
  • erectile dysfunction
  • medication
  • About RXFast.net
  • Terms & Conditions
  • Privacy Policy
  • GDPR Compliance Framework
  • Contact Us

©2026 rxfast.net. All rights reserved